Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,995 | 27 | 74.2% |
| Food and Beverage | $11,950 | 614 | 20.2% |
| Travel and Lodging | $3,006 | 9 | 5.1% |
| Consulting Fee | $290.00 | 1 | 0.5% |
| Gift | $49.99 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $46,787 | 97 | $0 (2024) |
| ABBVIE INC. | $5,476 | 160 | $0 (2022) |
| Janssen Biotech, Inc. | $1,353 | 68 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,266 | 70 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,218 | 70 | $0 (2022) |
| PFIZER INC. | $982.91 | 68 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $595.66 | 27 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $229.97 | 11 | $0 (2022) |
| RedHill Biopharma Inc. | $179.19 | 9 | $0 (2022) |
| Allergan, Inc. | $170.93 | 10 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104.83 | 1 | Gilead Sciences, Inc. ($104.83) |
| 2023 | $120.10 | 6 | NESTLE HEALTHCARE NUTRITION INC. ($120.10) |
| 2022 | $9,431 | 97 | Gilead Sciences, Inc. ($7,929) |
| 2021 | $8,142 | 133 | Gilead Sciences, Inc. ($5,727) |
| 2020 | $3,830 | 87 | Gilead Sciences, Inc. ($2,432) |
| 2019 | $13,872 | 119 | Gilead Sciences, Inc. ($12,263) |
| 2018 | $18,993 | 117 | Gilead Sciences, Inc. ($14,871) |
| 2017 | $4,797 | 94 | Gilead Sciences Inc ($3,460) |
All Payment Transactions
654 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $104.83 | General |
| 06/12/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/25/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/27/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 03/15/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 02/24/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 01/27/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/03/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/25/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $2.88 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/06/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/03/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Gastroenterology | ||||||
| 07/14/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Gastroenterology | ||||||
| 07/07/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 07/01/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $11.87 | General |
| Category: Neuroscience | ||||||
| 06/30/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: IMMUNOLOGY | ||||||
| 06/29/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Gastroenterology | ||||||
| 06/28/2022 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: GI | ||||||
| 06/28/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.68 | General |
| 06/22/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.24 | General |
| Category: Neuroscience | ||||||
| 06/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: Gastroenterology | ||||||
| 06/21/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Immunology | ||||||
| 06/09/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.54 | General |
| Category: Neuroscience | ||||||
| 06/08/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: VIROLOGY | ||||||
| 06/08/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 173 | 245 | $73,046 | $14,377 |
| 2021 | 9 | 377 | 454 | $190,300 | $37,144 |
| 2020 | 7 | 277 | 344 | $151,353 | $29,746 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 84 | 156 | $14,196 | $6,263 | 44.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 24 | 24 | $19,608 | $3,154 | 16.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $15,584 | $2,196 | 14.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $19,688 | $1,431 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $2,265 | $907.04 | 40.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 11 | 11 | $1,705 | $426.17 | 25.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 96 | 160 | $14,560 | $7,064 | 48.5% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 51 | 51 | $41,667 | $6,733 | 16.2% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 39 | 40 | $38,960 | $5,894 | 15.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 53 | 54 | $46,224 | $4,820 | 10.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 66 | $9,966 | $3,942 | 39.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 18 | 18 | $19,764 | $3,600 | 18.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 35 | 35 | $7,840 | $3,029 | 38.6% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 13 | 13 | $8,684 | $1,119 | 12.9% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 17 | 17 | $2,635 | $942.25 | 35.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 102 | 166 | $25,066 | $9,575 | 38.2% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 33 | 33 | $32,142 | $5,232 | 16.3% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 33 | 33 | $26,961 | $4,651 | 17.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 20 | 20 | $21,960 | $4,209 | 19.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 43 | 44 | $37,664 | $3,657 | 9.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 24 | 24 | $5,376 | $1,632 | 30.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 22 | 24 | $2,184 | $790.55 | 36.2% |
About Dr. Alan Epstein, M.D
Dr. Alan Epstein, M.D is a Gastroenterology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831157908.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Epstein, M.D has received a total of $59,290 in payments from pharmaceutical and medical device companies, with $104.83 received in 2024. These payments were reported across 654 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($43,995).
As a Medicare-enrolled provider, Epstein has provided services to 827 Medicare beneficiaries, totaling 1,043 services with total Medicare billing of $81,267. Data is available for 3 years (2020–2022), covering 22 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Providence, RI
- Active Since 05/01/2006
- Last Updated 01/22/2013
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1831157908
Products in Payments
- Epclusa (Drug) $42,745
- Mavyret (Drug) $2,816
- STELARA (Biological) $1,339
- XIFAXAN (Drug) $1,127
- HUMIRA (Biological) $761.53
- XELJANZ (Drug) $690.39
- ZENPEP (Drug) $619.52
- Entyvio (Biological) $605.09
- Creon (Drug) $544.20
- ENTYVIO (Biological) $497.34
- LINZESS (Drug) $473.96
- Humira (Biological) $378.27
- INFLECTRA (Biological) $272.88
- CREON (Drug) $236.11
- TRULANCE (Drug) $203.39
- MAVYRET (Drug) $198.36
- Talicia (Drug) $159.61
- ZEPOSIA (Drug) $149.55
- Linzess (Drug) $125.64
- Viekira (Drug) $111.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Providence
Thomas Sepe, Md, MD
Gastroenterology — Payments: $383,523
Paul Akerman, Md, MD
Gastroenterology — Payments: $163,964
Sean Fine, M.d, M.D
Gastroenterology — Payments: $63,236
Samir Shah, M.d, M.D
Gastroenterology — Payments: $45,756
Lisa Mueller, Md, MD
Gastroenterology — Payments: $22,692
Eric Newton, Md, MD
Gastroenterology — Payments: $20,736